| Literature DB >> 32061628 |
Laís Fernanda Machado1, Raquel Arruda Sanfelice1, Larissa Rodrigues Bosqui1, João Paulo Assolini1, Sara Scandorieiro2, Italmar Teodorico Navarro3, Allan Henrique Depieri Cataneo4, Pryscilla Fanini Wowk4, Gerson Nakazato2, Juliano Bordignon4, Wander Rogerio Pavanelli1, Ivete Conchon-Costa1, Idessania Nazareth Costa5.
Abstract
The highlights of biogenic silver nanoparticles (AgNp-Bio) include low toxicity - depending on size and concentration - and efficient antiparasitic activity. Therefore, the objective of this study was to assess the action of the AgNp-Bio on HeLa cells in an infection with strain of RH Toxoplasma gondii. Firstly, we performed a cellular viability test and characterized the AgNp-Bio to proceed with the infection of HeLa cells with T. gondii to be treated using AgNp-Bio or conventional drugs. Subsequently, we determined the level of standard cytokines Th1/Th2 as well as the content of nitric oxide (NO) and reactive oxygen species (ROS). Results indicated a mean size of 69 nm in diameter for the AgNp-Bio and obtained a dose-dependent toxicity. In addition, the concentrations of 3 and 6 μM promoted a significant decrease in adherence, infection, and intracellular proliferation. We also found lower IL-8 and production of inflammatory mediators. Thus, the nanoparticles reduced the adherence, infection, and proliferation of ROS and NO, in addition to immunomodulating the IL-8. Therefore, our data proved relevant to introduce a promising therapeutic alternative to toxoplasmosis.Entities:
Keywords: HeLa cells; Silver nanoparticles; Toxoplasmosis; Treatment
Year: 2020 PMID: 32061628 DOI: 10.1016/j.exppara.2020.107853
Source DB: PubMed Journal: Exp Parasitol ISSN: 0014-4894 Impact factor: 2.011